CannBioRx Life Sciences C... (ATNFW)
0.01
-0.00 (-2.91%)
At close: Jan 15, 2025, 2:58 PM
0.01
1.05%
After-hours Jan 15, 2025, 02:59 PM EST
undefined% (undefined)
| Bid | 0.01 |
| Market Cap | 9.21K |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.01 |
| Volume | 759,643 |
| Avg. Volume (20D) | 0 |
| Open | 0.01 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.01 - 0.01 |
| Beta | undefined |
About ATNFW
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is he...
Industry Medical - Pharmaceuticals
Sector Healthcare
IPO Date n/a
Employees 4
Stock Exchange NASDAQ
Ticker Symbol ATNFW
Website http://www.180lifesciences.com